Importantly, immunohistochemistry studies revealed that, in many refractory metastatic papillary carcinomas, the reduction in the I− uptake involves impaired NIS transport and residence at the plasma [18,72]. The gene discussed is SLC5A5; the disease is papillary carcinoma.